Collegium director exercises options, sells 8,700 shares
Collegium Pharmaceutical director Garen G. Bohlin exercised stock options and sold the resulting shares in a same-day transaction.
Rhea-AI Filing Summary
Collegium Pharmaceutical director Garen G. Bohlin exercised stock options and sold the resulting shares in a same-day transaction. On May 11, 2026, Bohlin exercised options for 8,700 shares of common stock at $16.49 per share, then completed an open-market sale of 8,700 shares at a weighted average price of $37.1829 per share. The sale price reflects multiple trades between $37.18 and $37.43. After these transactions, Bohlin directly holds 62,259 shares of Collegium Pharmaceutical common stock, with the exercised option position reduced to zero.
Positive
- None.
Negative
- None.
Insider Trade Summary
Exercise and Sale: 8,700 shares ($180K approx. pre-tax spread)
Exercise and Sale
3 txns
Insider
BOHLIN GAREN G
Role
Director
Sold
8,700 shs ($323K)
Approx. gross sale proceeds
$323K
Approx. exercise cost
$143K
Approx. pre-tax spread
$180K
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Purchase) | 8,700 | $0.00 | $0.00 |
| Exercise | Common Stock | 8,700 | $16.49 | $143K |
| Sale | Common Stock | 8,700 | $37.1829 | $323K |
Holdings After Transaction:
Stock Option (Right to Purchase) — 0 contracts (Direct);
Common Stock — 62,259 shares (Direct)
Footnotes (2)
- F1. The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $37.18 to $37.43, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F2. The option is fully vested and exercisable.
Key Figures
Shares sold: 8,700 shares
Weighted average sale price: $37.1829 per share
Option exercise price: $16.49 per share
+3 more
6 metrics
Shares sold
8,700 shares
Open-market sale of common stock on May 11, 2026
Weighted average sale price
$37.1829 per share
Multiple transactions between $37.18 and $37.43
Option exercise price
$16.49 per share
Exercise of stock option covering 8,700 shares
Shares held after transactions
62,259 shares
Direct common stock ownership after exercise and sale
Shares exercised from option
8,700 shares
Stock Option (Right to Purchase) converted into common stock
Option expiration date
June 9, 2026
Expiration for the exercised stock option grant
Key Terms
open-market sale, derivative exercise/conversion, Stock Option (Right to Purchase), weighted average price, +1 more
5 terms
open-market sale financial
"transaction_action: "open-market sale" for 8,700 common shares"
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
derivative exercise/conversion financial
"transaction_action: "derivative exercise/conversion" for option and common stock"
Stock Option (Right to Purchase) financial
"security_title: "Stock Option (Right to Purchase)" with 8,700 underlying shares"
weighted average price financial
"The price reported in column 4 is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
fully vested and exercisable financial
"The option is fully vested and exercisable."
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did COLLEGIUM PHARMACEUTICAL (COLL) report for Garen G. Bohlin?
Collegium Pharmaceutical reported that director Garen G. Bohlin exercised options for 8,700 common shares at $16.49 and sold 8,700 shares in the open market. These transactions occurred on May 11, 2026 as a combined exercise-and-sell event.
What stock options did Garen G. Bohlin exercise in the latest COLLEGIUM PHARMACEUTICAL (COLL) Form 4?
Bohlin exercised a fully vested stock option covering 8,700 shares of Collegium Pharmaceutical common stock at a $16.49 exercise price. Following this exercise, the option position reported in the filing shows zero remaining derivative shares outstanding from that particular grant.
AI-generated analysis. How Rhea-AI works. Not financial advice.
